Viewing Study NCT05341193


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2026-03-05 @ 2:31 PM
Study NCT ID: NCT05341193
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-04-22
First Post: 2022-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None antiangiogenesis View
None immunotherapy View
None Locoregionally Advanced Nasopharyngeal Carcinoma View